# EDGAR Filing Document

**Accession Number:** 0001651932
**File Stem:** 0001640334-23-000209
**Filing Date:** 2023-2
**Character Count:** 44646
**Document Hash:** 42005cbe8a00231e303c8dea459b6571
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001640334-23-000209.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001640334-23-000209

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 33

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Xenous Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001651932
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 870363526
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55512
- **FILM NUMBER:** 23621706

**BUSINESS ADDRESS:**
- **STREET 1:** SUITE 20.03, PLAZA 138, JALAN AMPANG
- **CITY:** KUALA LUMPUR
- **STATE:** N8
- **ZIP:** 50450
- **BUSINESS PHONE:** 603 2181 0150

**MAIL ADDRESS:**
- **STREET 1:** SUITE 20.03, PLAZA 138, JALAN AMPANG
- **CITY:** KUALA LUMPUR
- **STATE:** N8
- **ZIP:** 50450

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** M101 CORP.
- **DATE OF NAME CHANGE:** 20171103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Concept Holding Corp.
- **DATE OF NAME CHANGE:** 20150827

?xml version="1.0" encoding="utf-8"?xito_10q.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q**

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended **December 31, 2022**

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

For the transition period from ____________ to ______________

Commission file number: **000-55512**

---

| |
|:---|
| **XENOUS HOLDINGS, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Nevada** | **87-0363526** |
| (State or other jurisdiction <br>of incorporation or organization) | (IRS Employer <br>Identification No.) |

---

**Room 1120, 11th Floor, Peninsula Centre,** 

**67 Mody Road**

**Tsim Sha Tsui, East Kowloon**

**<u>Hong Kong</u>**

(Address of principal executive offices)

**<u>+852 6464-2017</u>**

(Registrant's telephone number)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class:** | **Trading Symbol(s)** | **Name of each exchange** <br>**on which registered:** |
| Common Stock | XITO | OTC Pink Sheets |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated Filer | ☐ | Smaller reporting company | ☒ |
| (Do not check if a smaller reporting company) | (Do not check if a smaller reporting company) | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

The number of shares of the issuer's common stock outstanding as of February 12, 2023 was 760,250,000 shares, par value $0.001 per share.

**XENOUS HOLDINGS, INC.**

**FORM 10-Q**

**Quarterly Period Ended December 31, 2022**

**INDEX**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| **PART I. FINANCIAL INFORMATION** | **PART I. FINANCIAL INFORMATION** |  |
| [Item 1.](#ii1) | [Financial Statements](#ii1) | 3 |
|  | [Balance Sheets as of December 31, 2022 and March 31, 2022 (unaudited)](#bs) | 3 |
|  | [Statements of Operations for the Nine Months and Three Months ended December 31, 2022 and 2010 (unaudited)](#op) | 4 |
|  | [Statements of Changes in Stockholders' Deficit for the Nine Months ended December 31, 2022 and 2021 (unaudited)](#def) | 5 |
|  | [Statements of Cash Flows for the Nine Months ended December 31, 2022 and 2021 (unaudited)](#cf) | 6 |
|  | [Notes to the Unaudited Condensed Financial Statements](#fs) | 7 |
| [Item 2.](#ii2) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#ii2) | 10 |
| [Item 3.](#ii3) | [Quantitative and Qualitative Disclosures About Market Risk](#ii3) | 13 |
| [Item 4.](#ii4) | [Controls and Procedures](#ii4) | 13 |
| **[PART II. OTHER INFORMATION](#p2)** | **[PART II. OTHER INFORMATION](#p2)** |  |
| [Item 1.](#i1) | [Legal Proceedings](#i1) | 14 |
| [Item 1A.](#i1a) | [Risk Factors](#i1a) | 14 |
| [Item 2.](#i2) | [Unregistered Sales of Equity Securities and Use of Proceeds](#i2) | 14 |
| [Item 3.](#i3) | [Defaults Upon Senior Securities](#i3) | 14 |
| [Item 4.](#i4) | [Mine Safety Disclosures](#i4) | 14 |
| [Item 5.](#i5) | [Other Information](#i5) | 14 |
| [Item 6.](#i6) | [Exhibits](#i6) | 15 |
| [SIGNATURES](#sig) | [SIGNATURES](#sig) | 16 |

---

---

| |
|:---|
| 2 |
| *[**Table of Contents**](#toc)* |

---

**Item 1. Financial Statements**

**XENOUS HOLDINGS, INC.**

**Balance Sheets**

---

| | | |
|:---|:---|:---|
|  | **December 31, 2022** | **March 31, 2022** |
|  | **(Unaudited)** | **(Audited)** |
| **ASSET**  |  |  |
| **Current Asset**  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | $- | $72 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current Asset | - | 72 |
| **TOTAL ASSET** | $- | $72 |
| **LIABILITIES AND STOCKHOLDERS' DEFICIT**  |  |  |
| **Current Liabilities**  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $9284 | $18157 |
| &nbsp;&nbsp;&nbsp;&nbsp;Due to a related party | 747627 | 699617 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current Liabilities | 756911 | 717774 |
| **TOTAL LIABILITIES**  | 756911 | 717774 |
| **STOCKHOLDERS' DEFICIT**  |  |  |
| Preferred stock, par value $0.001 per share, 10,000,000 shares authorized, no shares issued and outstanding |  |  |
| Common stock, par value $0.001 per share, 10,000,000,000 shares authorized, 760,250,000 shares issued and outstanding | 760250 | 760250 |
| Capital deficiency | (449450) | (449450) |
| Accumulated deficit | (1067711) | (1028502) |
| Total Stockholders' Deficit | (756911) | (717702) |
| **TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT**  | $- | $72 |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

---

| |
|:---|
| 3 |
| *[**Table of Contents**](#toc)* |

---

**XENOUS HOLDINGS, INC.**

**Statements of Operations**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** | **For the Nine Months Ended** | **For the Nine Months Ended** |
|  | **December 31,**<br>**2022** | **December 31,**<br>**2021** | **December 31,**<br>**2022** | **December 31,**<br>**2021** |
| **OPERATING EXPENSES** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | $2 | $144 | $219 | $578 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 13580 | 13500 | 38990 | 44830 |
|  | 13582 | 13644 | 39209 | 45408 |
| **NET LOSS** | $(13582) | $(13644) | $(39209) | $(45408) |
| Basic and Diluted Loss per Common Share | $(0.00) | $(0.00) | $(0.00) | $(0.00) |
| Basic and Diluted Weighted Average Number of Common Shares | 760250000 | 760250000 | 760250000 | 760250000 |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

---

| |
|:---|
| 4 |
| *[**Table of Contents**](#toc)* |

---

**XENOUS HOLDINGS, INC.**

**Statements of Changes in Stockholders' Deficit**

**For the nine months and three months ended December 31, 2022 and 2021**

**(Unaudited)**

**Nine months and three months ended December 31, 2022**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | <br>**Capital** | | |
|  | **Number of Shares** | **Amount** | **Deficiency** | <br>**Accumulated**<br>**Deficit** | **Total** <br>**Stockholders'**<br>**Deficit** |
| **Balance - March 31, 2022** | **760250000** | $**760250** | $**(449450)** | $**(1028502)** | $**(717702)** |
| Net loss | - | - | - | (11975) | (11975) |
| **Balance - June 30, 2022** | **760250000** | $**760250** | $**(449450)** | $**(1040477)** | $**(729677)** |
| Net loss | - | - | - | (13652) | (13652) |
| **Balance - September 30, 2022** | **760250000** | $**760250** | $**(449450)** | $**(1054129)** | $**(743329)** |
| Net loss | - | - | - | (13582) | (13582) |
| **Balance - December 31, 2022** | **760250000** | $**760250** | $**(449450)** | $**(1067711)** | $**(756911)** |

---

**Nine months and three months ended December 31, 2021**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | |
|  | **Number of Shares** | **Amount** | <br>**Capital**<br>**Deficiency** | <br>**Accumulated**<br>**Deficit** | **Total** <br>**Stockholders'**<br>**Deficit** |
| **Balance - March 31, 2021** | **760250000** | $**760250** | $**(449450)** | $**(963788)** | $**(652988)** |
| Net loss | - | - | - | (17895) | (17895) |
| **Balance - June 30, 2021** | **760250000** | $**760250** | $**(449450)** | $**(981683)** | $**(670883)** |
| Net loss | - | - | - | (13869) | (13869) |
| **Balance - September 30, 2021** | **760250000** | $**760250** | $**(449450)** | $**(995552)** | $**(684752)** |
| Net loss | - | - | - | (13644) | (13644) |
| **Balance - December 31, 2021** | **760250000** | $**760250** | $**(449450)** | $**(1009196)** | $**(698396)** |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

---

| |
|:---|
| 5 |
| *[**Table of Contents**](#toc)* |

---

**XENOUS HOLDINGS, INC.**

**Statements of Cash Flows**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months Ended** | **For the Nine Months Ended** |
|  | **December 31,** | **December 31,** |
|  | **2022** | **2021** |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |
| Net loss | $(39209) | $(45408) |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 72 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | (8873) | 28597 |
| Net cash used in operating activities | (48010) | (16811) |
| **CASH FLOWS FROM FINANCING ACTIVITY** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from related party advances | 48010 | 16811 |
| Net cash provided by financing activity | 48010 | 16811 |
| Net changes in cash and cash equivalents |  |  |
| Cash and cash equivalents - beginning of period | - | - |
| Cash and cash equivalents - end of period | $- | $- |
| Supplemental Cash Flow Disclosures |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $- | $- |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes | $- | $- |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

---

| |
|:---|
| 6 |
| *[**Table of Contents**](#toc)* |

---

**XENOUS HOLDINGS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

**December 31, 2022**

**NOTE 1 - NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS**

Xenous Holdings, Inc. (the "Company") was incorporated on May 20, 1980 as Dayne Weiss and Associates, Inc. under the laws of the State of Utah.

On December 19, 2014, the Company completed a change of domicile merger with Concept Holding Corp., a Nevada corporation, which became the surviving entity.

On July 21, 2017, the Board of Directors of the Company elected to file Articles of Merger with the Nevada SOS whereby it would enter into a statutory merger with its wholly-owned subsidiary, M101 Corp., a Nevada corporation, pursuant to Nevada Revised Statutes 92A.200, et seq. The effect of such merger is the Company is the surviving entity and changed its name to "M101 Corp." The merger took effect on August 14, 2017.

On November 2, 2019, a majority of shareholders approved a resolution to change the name of the Company to Xenous Holdings, Inc. On November 19, 2019, the Company received notice that the Secretary of State of Nevada accepted the Company's Certificate of Amendment to its Articles of Incorporation to change the name of the Company to Xenous Holdings, Inc. The Company currently has no business operations.

On November 11, 2022, the Company entered into a Memorandum of Understanding with Dadvance Agarwood Alpha Sdn Bhd ("Dadvance"), a company primarily engaged in the plantations, inoculations, cultivations, manufacturing, marketing, trading and conducting research and development of agricultural commodities in relation to Aquilaria trees and its related products with their headquarter based in Malaysia. The Company will be conducting full financial and legal due diligence of Dadvance and, if the due diligence is satisfactory, negotiate the definite acquisition agreement with Dadvance and its shareholders. The Board of Directors will not proceed with the acquisition unless an independent fairness opinion regarding fairness of the acquisition is obtained. The Company engaged YYC Advisors, a Malaysian accounting and financial advisory to conduct independent valuation on the targeted Malaysia plantation company. The Company engaged Eastnaga Capital Fund Ltd as an advisor and manager for corporate strategy.

**NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Presentation**

The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the nine months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the year ending March 31, 2023. The notes to the unaudited financial statements are condensed, as disclosures that would substantially duplicate the disclosures contained in the audited financial statements for fiscal year 2022 have been omitted. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended March 31, 2022 included in the Company's Form 10-K as filed with the Securities and Exchange Commission on June 29, 2022.

**Use of Estimates**

The Company prepares its financial statements in conformity with "GAAP," which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

**Fair Value of Financial Instruments**

ASC 820 "*Fair Value Measurements and Disclosures*" establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

These tiers include:

Level 1: defined as observable inputs such as quoted prices in active markets;

Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and

Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

---

| |
|:---|
| 7 |
| *[**Table of Contents**](#toc)* |

---

The Company's financial instruments consist primarily of accounts payable and debts. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments.

**Basic and Diluted Earnings Per Share** 

The Company has adopted ASC Topic 260, *"Earnings per Share,"*("EPS") which requires presentation of basic EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.

As of December 31, 2022 and 2021, the Company did not have any potentially dilutive securities.

**Related Parties**

We follow ASC 850, *"Related Party Disclosures,"* for the identification of related parties and disclosure of related party transactions (see Note 4).

**COVID-19**

In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID-19) outbreak a pandemic. This pandemic has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company's results of operations and financial position at December 31, 2022. The full extent of the future impacts of COVID-19 on the Company's operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company in the future. The Company is *not* aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of this Annual Report on Form *10*-Q. These estimates *may* change, as new events occur and additional information is obtained.

**Recently Issued Accounting Pronouncements**

In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the accounting for income taxes. This guidance will be effective for entities for the fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 on a prospective basis, with early adoption permitted. We adopted the new standard effective April 1, 2021 and there was no material impact on the Company's financial statements.

Management has considered all recent accounting pronouncements issued. The Company's management believes that these recent pronouncements will not have a material effect on the Company's financial statements.

**NOTE 3 - GOING CONCERN**

The Company has not yet generated any revenue since its inception and has an operating loss and net loss of $39,209 for the nine months ended December 31, 2022. As of December 31, 2022, the Company has accumulated deficit of $1,067,711, negative operating cash flow of $48,010 and negative working capital of $756,911. The Company's continuation as a going concern is dependent on its ability to execute its operation plan to generate sufficient cash flows from operations to meet its obligations and/or obtaining additional financing from its major shareholders or other sources, as may be required. There can be no assurance that the necessary debt or equity financing will be available or will be available on terms acceptable to the Company.

---

| |
|:---|
| 8 |
| *[**Table of Contents**](#toc)* |

---

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern; however, the above conditions raise substantial doubt about the Company's ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

While we believe in the viability of our strategy to generate sufficient revenues in the future and in our ability to raise additional funds, there can be no assurances to that effect.

**NOTE 4 - RELATED PARTY TRANSACTIONS**

**Due to Related Party**

During the nine months ended December 31, 2022 and 2021, Smartex Investment Ltd., the majority shareholder of the Company which is holding 82% of the Company's common shares, advanced $48,010 and $16,811, respectively, to the Company for operating expenses. As of December 31, 2022 and March 31, 2022, total amount due to Smartex Investment Ltd. was $747,627 and $699,617 respectively. The loan is non-interest bearing and due on demand.

**NOTE 5 – SHARE CAPITAL**

**Preferred Stock**

The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share. As of December 31, 2022 and March 31, 2022, no preferred shares have been issued.

**Common Stock**

The Company is authorized to issue 10,000,000,000 shares of common stock with a par value of $0.001 per share.

There were no stock issuances during the nine months ended December 31, 2022 and 2021. As of December 31, 2022 and March 31, 2022, the Company had 760,250,000 shares of common stock issued and outstanding.

**NOTE 6 – SUBSEQUENT EVENTS**

The due diligence process related to the acquisition plan with Dadvance Agarwood Alpha Sdn Bhd ("Dadvance") is still in progress as at the date of this filing, and upon satisfactory only, the Company shall execute a separate share purchase agreement based on the valuation report.

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2022 to the date these financial statements were issued and has determined that it does not have other material subsequent events to disclose in these financial statements.

---

| |
|:---|
| 9 |
| *[**Table of Contents**](#toc)* |

---

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS.**

When used in this Quarterly Report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," and similar expressions are intended to identify forward-looking statements regarding events, conditions, and financial trends that may affect our future plans of operations, business strategy, operating results, and financial position. Persons reviewing this Quarterly Report are cautioned that any forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Such factors are discussed further below and also include general economic factors and conditions that may directly or indirectly impact our financial condition or results of operations.

***Plan of Operation***

Our plan of operation for the next 12 months is to: (i) consider guidelines of industries in which we may have an interest; (ii) adopt a business plan regarding engaging in the business of any selected industry; and (iii) to commence such operations through funding and/or the acquisition of a "going concern" engaged in any industry selected.

During the next 12 months, our only foreseeable cash requirements will relate to maintaining our good standing or the payment of expenses associated with legal fees, accounting fees and reviewing or investigating any potential business venture, which may be advanced by management or principal stockholders as loans to us. Because we have not determined any business or industry in which our operations will be commenced, and we have not identified any prospective venture as of the date of this Annual Report, it is impossible to predict the amount of any such loan. Any such loan will be on terms no less favorable to us than would be available from a commercial lender in an arm's length transaction. No advance or loan from any affiliate will be required to be repaid as a condition to any agreement with future acquisition partners.

---

| |
|:---|
| 10 |
| *[**Table of Contents**](#toc)* |

---

***Results of Operations***

***Three Months Ended December 31, 2022 and 2021***

---

| | | | |
|:---|:---|:---|:---|
|  | **Three Months**<br>**Ended**<br>**December 31,**<br>**2022** | **Three Months**<br>**Ended**<br>**December 31,**<br>**2021** | <br><br>**Changes** |
| Operating Expenses | $13582 | $13644 | $(62) |
| Net Loss | $(13582) | $(13644) | $62 |

---

We had no operations during the three months ended December 31, 2022 or 2021, nor do we have operations as of the date of this filing. We had a net loss of $13,582 and $13,644 for the three months ended December 31, 2022 and 2021, respectively. The decrease was mainly attributable to the decrease in general and administrative expense incurred during the three months ended December 31, 2022.

***Nine Months Ended December 31, 2022 and 2021***

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine Months**<br>**Ended**<br>**December 31,**<br>**2022** | **Nine Months**<br>**Ended**<br>**December 31,**<br>**2021** | <br><br>**Changes** |
| Operating Expenses | $39209 | $45408 | $(6199) |
| Net Loss | $(39209) | $(45408) | $6199 |

---

We had no operations during the nine months ended December 31, 2022 or 2021, nor do we have operations as of the date of this filing. We had a net loss of $39,209 and $45,408 for the nine months ended December 31, 2022 and 2021, respectively. The decrease was mainly attributable to the decrease in professional fees incurred during the nine months ended December 31, 2022. Professional fees were $38,990 and $44,830 for the nine months ended December 31, 2022 and 2021, respectively.

***Liquidity and Capital Resources***

---

| | | | |
|:---|:---|:---|:---|
|  | **As of**<br>**December 31,**<br>**2022** | **As of**<br>**March 31,**<br>**2022** | <br><br>**Changes** |
| Current Asset | $- | $72 | $(72) |
| Current Liabilities | $756911 | $717774 | $39137 |
| Working Capital (Deficiency) | $(756911) | $(717702) | $(39209) |

---

---

| |
|:---|
| 11 |
| *[**Table of Contents**](#toc)* |

---

As of December 31, 2022 and March 31, 2022, we had no current asset.

As of December 31, 2022 and March 31, 2022, our total liabilities were $756,911 and $717,774, respectively, which were current liabilities comprised of accounts payable, accrued liabilities, and related party advances.

Stockholders' deficit was at $756,911 as of December 31, 2022 compared to deficit of $717,702 as of March 31, 2022.

We had no cash on hand as of December 31, 2022 or March 31, 2022 to meet ongoing expenses and debts that may accumulate. Accumulated deficit was at $1,067,711 as of December 31, 2022, compared to accumulated deficit of $1,028,502 as of March 31, 2022.

As of December 31, 2022, we had a working capital deficit of $756,911 compared with a working capital deficit of $717,702 as of March 31, 2022. The increase in working capital deficit was attributed to an increase in amount due to related party for advancement from the Company's majority shareholder paying off vendors on behalf of the Company.

---

| | | | |
|:---|:---|:---|:---|
|  | **Nine Months**<br>**Ended**<br>**December 31,**<br>**2022** | **Nine Months**<br>**Ended**<br>**December 31,**<br>**2021** | <br><br>**Changes** |
| Net cash used in operating activities | $(48010) | $(16811) | $(31199) |
| Net cash provided by financing activities | $48010 | $16811 | $31199 |
| Net changes in cash and cash equivalents | $- | $- | $- |

---

*Cash Flow from Operating Activities*

We have not generated any positive cash flow from operating activities.

For the nine months ended December 31, 2022, net cash flows used in operating activities was $48,010. The net cash used in operating activities for the nine months ended December 31, 2022 was attributed to a net loss of $39,209, increased by a decrease in accounts payable and accrued liabilities of $8,873 and decreased by a decrease in prepaid expense.

For the nine months ended December 31, 2021, net cash flows used in operating activities was $16,811. The net cash used in operating activities for the nine months ended December 31, 2021 was attributed to a net loss of $45,408, decreased by an increase in accounts payable and accrued liabilities of $28,597.

*Cash Flow from Investing Activities*

During the nine months ended December 31, 2022 and 2021, we had no investing activities.

*Cash Flow from Financing Activities*

We have financed our operations primarily from advances and loans from Smartex Investment Ltd., majority shareholder of the Company.

For the nine months ended December 31, 2022 and 2021, net cash from financing activities was $48,010 and $16,811, respectively.

---

| |
|:---|
| 12 |
| *[**Table of Contents**](#toc)* |

---

***Going Concern***

Our independent auditors have added an explanatory paragraph to their audit issued in connection with the financial statements for the year ended March 31, 2022, relative to our ability to continue as a going concern. The Company, which has not generated any revenues, has incurred net losses, has nominal assets and a stockholders' deficit. These conditions, among others, raise substantial doubt about the Company's ability to continue as a going concern. The Company's continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company is dependent on advances from its principal shareholders or other affiliated parties for continued funding. There are no commitments or guarantees from any third party to provide such funding nor is there any guarantee that the Company will be able to access the funding it requires to continue its operations.

***Off-Balance Sheet Arrangements***

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to an investor in our securities.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Pursuant to Item 305(e) of Regulation of S-K (§229.305(e)), the Company is not required to provide the information required by this Item as it is a "smaller reporting company," as defined by Rule 229.10(f)(1).

**ITEM 4. CONTROLS AND PROCEDURES**

***Disclosure Controls and Procedures***

Disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules and forms adopted by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Secretary, to allow timely decisions regarding required disclosures.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Secretary, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report. Based upon that evaluation, our Chief Executive Officer and Secretary concluded that, as of the end of the period covered by this Quarterly Report, our disclosure controls and procedures were not effective.

***Changes in Internal Control Over Financial Reporting***

During the fiscal quarter covered by this Quarterly Report, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

---

| |
|:---|
| 13 |
| *[**Table of Contents**](#toc)* |

---

**PART II – OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS** 

Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us.

**ITEM 1A. RISK FACTORS** 

As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** 

There were no unregistered sales of our equity securities during the period covered by this quarterly report.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES** 

None.

**ITEM 4. MINE SAFETY DISCLOSURES** 

Not applicable.

**ITEM 5. OTHER INFORMATION** 

None.

---

| |
|:---|
| 14 |
| *[**Table of Contents**](#toc)* |

---

**ITEM 6. EXHIBITS** 

Exhibits:

---

| | |
|:---|:---|
| [31.1](xito_ex311.htm) | [Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Executive Officer](xito_ex311.htm) |
| [31.2](xito_ex312.htm) | [Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Financial Officer](xito_ex312.htm) |
| [32.1](xito_ex321.htm) | [Section 1350 Certification by Chief Executive Officer](xito_ex321.htm) |
| [32.2](xito_ex322.htm) | [Section 1350 Certification by Chief Financial Officer](xito_ex322.htm) |

---

---

| |
|:---|
| 15 |
| *[**Table of Contents**](#toc)* |

---

**SIGNATURES**

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **XENOUS HOLDINGS, INC.** | **XENOUS HOLDINGS, INC.** |
| DATED: February 14, 2023 | By: | */s/ Jonathan Chan Ye Earn* |
|  |  | Jonathan Chan Ye Earn |
|  |  | Chief Executive Officer (Principal Executive Officer) |
|  | By: | */s/ Mak Jee Wan* |
|  |  | *Mak Jee Wan* |
|  |  | Treasurer (Principal Financial Officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION PURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a)**

**<u>OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</u>**

I, Jonathan Chan Ye Earn, Chief Executive Officer of Xenous Holdings, Inc., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Xenous Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure control and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 14, 2023

---

| | |
|:---|:---|
| By: | */s/ Jonathan Chan Ye Earn* |
| Name: | Jonathan Chan Ye Earn |
| Title: | Chief Executive Officer (Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION PURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a)**

**<u>OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</u>**

I, Stephanie Mak, Chief Financial Officer of Xenous Holdings, Inc., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Xenous Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure control and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 14, 2023

---

| | |
|:---|:---|
| By: | */s/ Stephanie Mak* |
| Name: | Stephanie Mak |
| Title: | Chief Financial Officer (Principal Financial Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO**

**<u>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</u>**

In connection with the Quarterly Report of Xenous Holdings, Inc. (the "Company") on Form 10-Q for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 14, 2023

---

| | |
|:---|:---|
| By: | */s/ Jonathan Chan Ye Earn* |
| Name: | Jonathan Chan Ye Earn |
| Title: | Chief Executive Officer (Principal Executive Officer) |

---

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO**

**<u>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</u>**

In connection with the Quarterly Report of Xenous Holdings, Inc. (the "Company") on Form 10-Q for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 14, 2023

---

| | |
|:---|:---|
| By: | */s/ Stephanie Mak* |
| Name: | Stephanie Mak |
| Title: | Chief Financial Officer (Principal Financial Officer) |

---